
    
      All the subjects whom an investigator prescribes the first Amlodipine /Atorvastatin (CaduetÂ®)
      Combination Tablets should be registered consecutively until the number of subjects reaches
      target number in order to extract patients enrolled into the investigation at random.
    
  